Retaining its recent growth momentum, Bengal Chemicals and Pharmaceuticals Ltd on Tuesday reported a net profit of Rs 16.3 crore for the nine months ended December.
For the full 2018-19 fiscal, it is expected to post a bottomline of Rs 22 crore, a company official said.
Bengal Chemicals, the country's first pharmaceuticals company, is aiming to double the profit for the year, after "aggressive transformation" measures were undertaken by Managing Director P M Chandraiah, the official said.
In 2017-18, the company had recorded a net profit of Rs 10.6 crore.
Bengal Chemicals had ended a continuous span of running into losses for 50 years in 2013-14, managing to be back in the black with a Rs 4.5-crore profit, he added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app